Breast cancer
Conditions
Interventions
Overview of the Surgical Technique
Technology: Image-guided technology (VINCENT by FUJIFILM, head-mounted device HoloLens 2 by Microsoft).
Procedure: Breast-conserving surgery is performed, with rese
Sponsors
Hirofumi Terakawa
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Disease and Diagnostic Methods - Disease: Early-stage breast cancer. - Diagnostic Methods: Diagnosis is made in accordance with the "Breast Cancer Treatment Guidelines, 8th Edition," using mammography, ultrasound, and, if necessary, MRI or biopsy. 2) Stage and Type of Cancer - Stage: Stage I or Stage II breast cancer. 3) Age - Age: Patients aged 20 years or older. 4) Sex - Sex: Female. 5) Performance Status - Performance Status (ECOG):Patients with an ECOG performance status of 1 or lower. 6) Written Consent from Patients - Written Consent: Patients who have provided written consent to participate in this study after receiving sufficient informed consent and of their own free will.
Exclusion criteria
Exclusion criteria: 1) Patients who have participated in other clinical trials (including drug trials) within the past 3 months. 2) Patients who are receiving preoperative hormone therapy (such as oral anastrozole) or preoperative chemotherapy. 3) Patients with significant comorbidities (such as heart failure, progressive liver or kidney disease, severe diabetes, etc.). 4) Patients whom the principal investigator or sub-investigator deems inappropriate for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical Time, Blood Loss, Secondary Additional Resection | — |
Secondary
| Measure | Time frame |
|---|---|
| cancer-positive at the edge of the breast tissue margin | — |
Contacts
Public ContactMohri Ryosuke
Department of Breast Surgery, Kanazawa Univercity Hospital
Outcome results
None listed